tm logo
MIRATI
REGISTERED

on 23 Aug 2024

Last Applicant/ Owned by

MIRATI THERAPEUTICS INC.

3545 Cray CourtSan Diego, CA 92121

US

Serial Number

2188646 filed on 30th May 2022

Registration Number

TMA1252358 registered on 23rd Aug 2024

Registration expiry Date

23rd Aug 2034

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

MIRATI

Trademark usage description

medicinal preparations for use in oncology; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceut Read More

Classification Information


Class [005]
Medicinal preparations for use in oncology; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceuticals for the prevention and treatment of cancer; pharmaceuticals for the treatment of cancer;


Classification kind code

11

Class [042]
Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research on the subject of pharmaceuticals; scientific research for medical purposes in the field of cancerous diseases;


Classification kind code

11

Mark Details


Serial Number

2188646

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 23rd Aug 2024
Registration Pending
Submitted for opposition 42
on 05th Jun 2024
Advertised
Submitted for opposition 26
on 13th May 2024
Approved
Submitted for opposition 27
on 13th May 2024
Approval Notice Sent
Submitted for opposition 22
on 18th Oct 2023
Search Recorded
Submitted for opposition 20
on 18th Oct 2023
Examiner's First Report
Submitted for opposition 67
on 07th Oct 2022
Agent Name Changed
Submitted for opposition 30
on 30th May 2022
Filed
Submitted for opposition 1
on 30th May 2022
Created
Submitted for opposition 31
on 30th May 2022
Formalized